India Value Fund Advisors to pick up 10% stake in Biocon unit1 min read . Updated: 18 Sep 2014, 07:01 PM IST
The private equity firm is buying the 10% stake from Biocon Research
The private equity firm is buying the 10% stake from Biocon Research Ltd (BRL), the companies said in a joint statement.
After the completion of this transaction, Biocon and BRL will jointly hold 85.54% stake in Syngene.
Biocon group was advised by Allegro Advisors on the transaction.